485.00
0.00
(0.00%)
At close: April 9 at 1:45:58 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 5 |
| Avg. Estimate | 4.06M | 8.79M | 50.59M | 284.28M |
| Low Estimate | 3M | 7.58M | 48M | 120M |
| High Estimate | 5M | 10M | 53.76M | 465.88M |
| Year Ago Sales | 500k | 900k | 4.42M | 50.59M |
| Sales Growth (year/est) | 712.50% | 877.08% | 1,045.03% | 461.96% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ASTS.MX | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 3/5/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/5/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/4/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 2/6/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 1/24/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/15/2024 |